Persistent Systems (PERSISTENT) Option Chain — Live Strike Data, OI & Greeks

Spot Price
Expiry Date

Understanding Persistent Systems' Option Chain


Persistent Systems — product engineering specialist with highest mid-cap IT growth

Persistent Systems Limited (PERSISTENT) is one of India's leading mid-cap IT services companies, with a distinctive specialisation: product engineering services for software ISVs (Independent Software Vendors) and digital transformation services for US healthcare clients. The company has consistently been among the fastest-growing mid-cap IT names through 2022-2026. Three structural facts shape Persistent's option market in ways that distinguish it from Coforge or large-cap IT:

  • Product engineering specialisation vs traditional IT services. Persistent focuses on building software products and platforms for client companies — particularly software ISVs (independent software vendors) like SaaS companies, software platforms, and tech companies. This is fundamentally different from traditional IT services like application development, maintenance, or BPO. Product engineering work is typically higher-margin, requires deeper engineering talent, and has stickier client relationships. The company's "Hi-Tech" and "Software & Hi-Tech" verticals are core competencies.
  • US healthcare and life sciences exposure. Persistent has significant exposure to US healthcare technology — including health insurance technology platforms, electronic health records integrations, and pharmaceutical/life sciences digital transformations. This vertical accounts for ~30% of revenue. US healthcare technology spending is one of the most resilient enterprise IT segments globally.
  • The Sandeep Kalra era growth story. Sandeep Kalra joined as CEO in 2019 (previously at Infosys, NIIT Technologies). Under his leadership, Persistent has delivered consistent above-industry-average growth — sustained 14-20% revenue growth in USD terms across multiple years, materially outpacing TCS and Infosys. The CEO's stated ambitions have included a $5 billion revenue target by 2030 (from current $1-1.5 billion levels). Continued execution on this growth trajectory is the central question.

For option traders, the practical implication is that Persistent has higher growth, lower margins (typically 18-20% EBITDA vs TCS's 24-26%), and different end-market exposures than large-cap IT or BFSI-focused mid-caps. IV is higher reflecting the growth-stock characteristics.


How to read Persistent's option chain

Three patterns specific to PERSISTENT:

  • Quarterly results IV cycle with growth-rate focus. Each quarterly result is scrutinised for sequential revenue growth rate (typically 3-5% sequential in good quarters), USD growth (annualised 14-20% target), large deal wins, and vertical-wise commentary. Surprises in either direction produce meaningful moves.
  • OI build-up around US tech-sector news. US software ISV spending trends, US healthcare technology budgets, and US tech sector earnings (Salesforce, Oracle, Workday, ServiceNow, SAP) all pre-signal Persistent's environment.
  • Heavy institutional positioning. Persistent is one of the most-held mid-cap IT stocks by mutual funds and FIIs. Large institutional rebalancing windows can affect short-term price action.


What moves Persistent Systems — and its options

Five drivers, in approximate order of impact:

  • Quarterly results. Persistent reports Q1 (Apr-Jun) in mid-July, Q2 (Jul-Sep) in mid-October, Q3 (Oct-Dec) in mid-January, and Q4 + annual in mid-April. Revenue growth (sequential and YoY in USD terms), EBITDA margins, deal wins (TCV), and vertical performance are all scrutinised.
  • US software ISV environment. Persistent's largest customer segment is software ISVs. US software industry trends — M&A activity, IPOs, layoffs, capex cycles — affect Persistent's demand environment.
  • US healthcare technology spending. The healthcare vertical (~30% of revenue) is sensitive to US healthcare insurance reform, hospital IT spending, and pharmaceutical R&D budgets.
  • USD/INR. Like other Indian IT, Persistent derives substantial revenue in USD. Currency moves affect quarterly translation.
  • Sector rotation. When mid-cap IT rotates as a basket (Coforge, Persistent, LTIMindtree, Mphasis), correlation flows affect Persistent.


PERSISTENT IV — context for current readings

Persistent's typical implied volatility range is 28-40% in calm market conditions, expanding to 45-60% before quarterly results. This is higher than large-cap IT services (TCS 17-26%, Infosys 19-28%) because of Persistent's mid-cap status, higher growth rate, and growth-stock characterisation. [VERIFY: cross-check IV against the live column.]


How professionals trade Persistent Systems options

Three approaches:

  1. Pre-results long volatility. Persistent's quarterly results have produced larger-than-implied moves consistently because growth surprises are common. Long straddles 7-10 days before results with strict exit discipline.
  2. Pair trades with Coforge. Both are mid-cap IT services but with different specialisations. When Persistent diverges meaningfully from Coforge on no obvious news, the spread can converge.
  3. US ISV cycle positioning. Major US software earnings (Salesforce, Oracle, Workday) reporting weeks can be leveraged through Persistent options if the read-through is meaningful.


Common mistakes when trading Persistent Systems options

Anchoring to TCS/Infosys patterns. Persistent's higher growth, different end-market exposure, and product engineering focus create different dynamics than large-cap IT. Strategies calibrated on TCS often misprice Persistent.

Underestimating US healthcare and software ISV sensitivity. Persistent's specific end-market exposure produces sensitivities that aren't visible in broader IT sector analysis. Following Salesforce earnings or US healthcare IT news can be more useful than following broader Indian IT.

Treating Persistent like Coforge. While both are mid-cap IT, Coforge is M&A-transformed BFSI-focused while Persistent is organic-growth product-engineering-focused. Different dynamics, different risks.


Related tools

Persistent Systems FAQs

Yes. Persistent's largest customer segment is software ISVs (Salesforce, Oracle, Workday, ServiceNow, SAP and other US software companies). Their quarterly earnings often pre-signal Persistent's demand environment. Strong US software earnings with positive commentary on product engineering spending often pre-signal positive Persistent quarters; weakness can pre-signal challenges. The relationship isn't perfect but provides useful leading indicators that pure-India IT analysis would miss.
Sandeep Kalra joined Persistent Systems as CEO in 2019 (previously at Infosys and NIIT Technologies). Under his leadership, Persistent has delivered consistently above-industry-average growth — sustained 14-20% USD revenue growth across multiple years, materially outpacing large-cap peers TCS and Infosys. He has articulated ambitions of $5 billion revenue by 2030 (from current $1-1.5 billion levels). Continued execution on this growth trajectory is the central question in the stock's medium-term thesis.
Persistent's healthcare vertical accounts for approximately 30% of revenue. The company serves US healthcare clients including health insurance technology platforms, electronic health records integrations, and pharmaceutical/life sciences digital transformations. US healthcare technology spending is one of the most resilient enterprise IT segments globally — driven by structural drivers (aging population, healthcare digitisation, regulatory compliance requirements). The vertical provides defensive characteristics relative to more cyclical IT spending.
PERSISTENT's option lot size is set by NSE/SEBI based on price levels and is reviewed periodically. Check our F&O Lot Size page for the current lot size.
Three layers of differentiation. First, scale: Persistent is mid-cap (~$1-1.5 billion revenue) vs TCS at ~$30 billion+. Second, specialisation: Persistent focuses on product engineering for software ISVs and US healthcare; Coforge focuses on BFSI; TCS does everything. Third, growth profile: Persistent has been the highest-growth in mid-cap IT (14-20% USD growth sustained), materially faster than TCS or Coforge. IV regimes and event sensitivities differ correspondingly.
Product engineering services means building software products and platforms for client companies — particularly software ISVs (Independent Software Vendors), SaaS companies, and tech companies. This is fundamentally different from traditional IT services like application development, maintenance, or BPO. Product engineering involves deeper engineering work — architecture design, platform development, ongoing product enhancement — with stickier client relationships and typically higher margins. Persistent's specialisation in this area gives it different competitive dynamics than traditional IT services companies.
Following SEBI's September 2025 derivatives reshuffle, NSE monthly stock options expire on the **last Tuesday** of the contract month.
Persistent's IV typically ranges 28-40% in calm market conditions, expanding to 45-60% before quarterly results. This is higher than large-cap IT services because of Persistent's mid-cap status and higher growth rate.
Persistent typically reports Q1 results in mid-July, Q2 in mid-October, Q3 in mid-January, and Q4 + annual in mid-April. Persistent follows the typical Indian IT services results cycle and is often among the earliest mid-cap IT companies to report each quarter.
The live chain above shows current call and put data for every strike around PERSISTENT's spot price, with OI, change in OI, volume, LTP, IV and Greeks. The chain refreshes during market hours.
Logo
search
  • Analytics
  • Backtesting
  • Options
  • Resources
  • Menu
  • Menu